CSL Therapy That Mimics “Good” Cholesterol May Reduce Plaque Volume in Coronary Arteries
VICTORIA, Australia, March 27, 2007--CSL Limitedtoday announced results from a study published in the Journal ofthe American Medical Association that suggest infusions of a novelnew drug, CSL-111, to acutely raise HDL (“good”cholesterol) levels, may reduce the amount of plaque in thecoronary arteries of patients with a recent episode of acutecoronary syndrome (AC...CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume in Coronary Arteries
NEW ORLEANS, March 26, 2007 /PRNewswire/ -- CSL Limited todayannounced results from a study published in the Journal of theAmerican Medical Association that suggest infusions of a novel newdrug, CSL-111, to acutely raise HDL ("good" cholesterol) levels,may reduce the amount of plaque in the coronary arteries ofpatients with a recent episode of acute coronary syndrome(ACS). ACS is...